Crossmark

Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56

Published Online: 2019-09-11

Authors

Zou, Fan

Lu, Lijuan

Liu, Jun

Xia, Baijin

Zhang, Wanying

Hu, Qifei

Liu, Weiwei

Zhang, Yiwen

Lin, Yingtong

Jing, Shuliang

Huang, Mei

Huang, Bifen

Liu, Bingfeng

Zhang, Hui
License Information

Text and Data Mining valid from 2019-09-11

Version of Record valid from 2019-09-11
More Information

Article History

Received: 7 August 2018

Accepted: 25 July 2019

First Online: 11 September 2019

Competing interests

: The authors declare no competing interests.

Document is current